235 related articles for article (PubMed ID: 20457981)
1. Inhibition of choroidal neovascularization by intravitreal ketorolac.
Kim SJ; Toma HS
Arch Ophthalmol; 2010 May; 128(5):596-600. PubMed ID: 20457981
[TBL] [Abstract][Full Text] [Related]
2. Improved assessment of laser-induced choroidal neovascularization.
Toma HS; Barnett JM; Penn JS; Kim SJ
Microvasc Res; 2010 Dec; 80(3):295-302. PubMed ID: 20553963
[TBL] [Abstract][Full Text] [Related]
3. Baicalin attenuates laser-induced choroidal neovascularization.
Yang SJ; Jo H; Kim JG; Jung SH
Curr Eye Res; 2014 Jul; 39(7):745-51. PubMed ID: 24502359
[TBL] [Abstract][Full Text] [Related]
4. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal infliximab and choroidal neovascularization in an animal model.
Olson JL; Courtney RJ; Mandava N
Arch Ophthalmol; 2007 Sep; 125(9):1221-4. PubMed ID: 17846362
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.
Gillies MC; Simpson JM; Luo W; Penfold P; Hunyor AB; Chua W; Mitchell P; Billson F
Arch Ophthalmol; 2003 May; 121(5):667-73. PubMed ID: 12742844
[TBL] [Abstract][Full Text] [Related]
8. Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF.
Kim SJ; Toma HS; Barnett JM; Penn JS
Exp Eye Res; 2010 Oct; 91(4):537-43. PubMed ID: 20659449
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation.
Kim SJ; Kim J; Lee J; Cho SY; Kang HJ; Kim KY; Jin DK
Br J Ophthalmol; 2013 Mar; 97(3):367-70. PubMed ID: 23258212
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
[TBL] [Abstract][Full Text] [Related]
11. Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model.
Criswell MH; Hu WZ; Steffens TJ; Li R; Margaron P
Arch Ophthalmol; 2008 Jul; 126(7):946-52. PubMed ID: 18625941
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histological findings after intravitreal injection of bevacizumab (Avastin) in a porcine model of choroidal neovascularization.
Lassota N; Prause JU; Scherfig E; Kiilgaard JF; la Cour M
Acta Ophthalmol; 2010 May; 88(3):300-8. PubMed ID: 19416113
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.
Yan H; Cui J; Wang Y; Yu Y
Ophthalmic Res; 2013; 49(2):81-9. PubMed ID: 23257710
[TBL] [Abstract][Full Text] [Related]
15. Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Nozaki M; Ogura Y
Retina; 2005 Jun; 25(4):503-9. PubMed ID: 15933599
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone.
Gomi F; Nishida K; Oshima Y; Sakaguchi H; Sawa M; Tsujikawa M; Tano Y
Am J Ophthalmol; 2007 Mar; 143(3):507-10. PubMed ID: 17317397
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
Jonas JB
Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
[TBL] [Abstract][Full Text] [Related]
18. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
[TBL] [Abstract][Full Text] [Related]
20. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
